These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10370935)
1. Antispasticity medications. Nance PW; Young RR Phys Med Rehabil Clin N Am; 1999 May; 10(2):337-55, viii. PubMed ID: 10370935 [TBL] [Abstract][Full Text] [Related]
2. Muscle relaxants and antispasticity agents. Meleger AL Phys Med Rehabil Clin N Am; 2006 May; 17(2):401-13. PubMed ID: 16616274 [TBL] [Abstract][Full Text] [Related]
3. The pharmacological management of spasticity. Saulino M; Jacobs BW J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517 [TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle relaxants. See S; Ginzburg R Pharmacotherapy; 2008 Feb; 28(2):207-13. PubMed ID: 18225966 [TBL] [Abstract][Full Text] [Related]
5. Tizanidine for spasticity. Med Lett Drugs Ther; 1997 Jul; 39(1004):62-3. PubMed ID: 9217694 [No Abstract] [Full Text] [Related]
6. The pharmacotherapy of spinal spasticity: a decade of progress. II. Therapeutics. Segatore M; Miller M SCI Nurs; 1995 Mar; 12(1):2-7. PubMed ID: 7792578 [TBL] [Abstract][Full Text] [Related]
7. Oral baclofen increases maximal voluntary neuromuscular activation of ankle plantar flexors in children with spasticity due to cerebral palsy. van Doornik J; Kukke S; McGill K; Rose J; Sherman-Levine S; Sanger TD J Child Neurol; 2008 Jun; 23(6):635-9. PubMed ID: 18281622 [TBL] [Abstract][Full Text] [Related]
8. Anti-spasticity medications. Al-Shahrani AM Saudi Med J; 2003 Jan; 24(1):19-22. PubMed ID: 12590267 [TBL] [Abstract][Full Text] [Related]
9. Muscle relaxants--the current position in the treatment of spasticity in orthopedics. Zygmunt M; Sapa J Ortop Traumatol Rehabil; 2015; 17(4):423-30. PubMed ID: 26468180 [TBL] [Abstract][Full Text] [Related]
10. Role of oral medications in spasticity management. Watanabe TK PM R; 2009 Sep; 1(9):839-41. PubMed ID: 19769918 [TBL] [Abstract][Full Text] [Related]
11. [Dantrolene. Pharmacological and therapeutic aspects]. Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006 [TBL] [Abstract][Full Text] [Related]
13. [Comparative efficacy of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity]. Koval'chuk VV; Skoromets AA; Vasil'eva IV Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):14-9. PubMed ID: 18833102 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of tizanidine. Roberts RC; Part NJ; Pokorny R; Muir C; Leslie GC; Emre M Neurology; 1994 Nov; 44(11 Suppl 9):S29-31. PubMed ID: 7970008 [TBL] [Abstract][Full Text] [Related]
15. Prospective assessment of tizanidine for spasticity due to acquired brain injury. Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic management of spasticity following stroke. Gallichio JE Phys Ther; 2004 Oct; 84(10):973-81. PubMed ID: 15449979 [No Abstract] [Full Text] [Related]
17. [Physical and other methods therapy of the spasticity in children]. SwierczyĆska A; Renata K; Jaworek M Przegl Lek; 2007; 64(11):974-7. PubMed ID: 18409416 [TBL] [Abstract][Full Text] [Related]
18. Tizanidine in the management of spasticity and musculoskeletal complaints in the palliative care population. Smith HS; Barton AE Am J Hosp Palliat Care; 2000; 17(1):50-8. PubMed ID: 11094920 [TBL] [Abstract][Full Text] [Related]